( 11 ) provide compelling evidence that GLP-1 signaling in the CNS also serves to increase noninsulin-dependent glucose uptake by muscle and stimulates insulin secretion via neural connections to these tissues.
However, the nature of optimal dietary support may differ between the two compounds
Hypoglycaemia risk When used as monotherapy, GLP-1 receptor agonists carry minimal hypoglycaemia risk due to their glucose-dependent mechanism
The main ongoing considerations are maintaining adequate protein intake (to preserve lean muscle mass during continued weight loss), keeping hydration consistent, and monitoring bloodwork periodically to confirm that liver, kidney, and metabolic markers remain healthy
Lower breast cancer rates across multiple analyses The researchers analyzed electronic health records from women who underwent breast imaging at Penn Medicine between January 2022 and June 2025
Layne Norton: That's the lining